Rhythm Pharmaceuticals (RYTM) Revenue (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) revenue from Sep 30, 2016 to Mar 31, 2026. The TTM Rhythm Pharmaceuticals (RYTM) revenue is $217M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Rhythm Pharmaceuticals (RYTM) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +58.67% |
| 3 Years TTM | +86.25% |
| 5 Years TTM | +458.40% |
Annual Revenue change of Rhythm Pharmaceuticals (RYTM)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $60M | -68.32% |
| 2025 | $190M | +45.82% |
| 2024 | $130M | +68.06% |
| 2023 | $77M | +227.54% |
| 2022 | $24M | +650.48% |
| 2021 | $3.15M | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
Comparison Rhythm Pharmaceuticals (RYTM) five years revenue CAGR with competitors
Rhythm Pharmaceuticals (RYTM) five years revenue CAGR is 473.51%.